Personal Genome Service For Carrier Screening Emerges From 23andMe Work With FDA
This article was originally published in The Tan Sheet
Two years of conversations with FDA lead 23andMe back to the health care market with the launch of its Personal Genome Service, focused on carrier screening tests. The firm says its close engagement with FDA improved its customer communication and quality control.
Register for our free email digests: